EQUIPOSE 250

Equipoise 250, also known as Boldenone Undecylenate, is an anabolic androgenic steroid (AAS) primarily used in veterinary medicine for horses. Although Equipoise 250 is not approved for human use, it is sometimes used illicitly by athletes and bodybuilders for its potential performance-enhancing effects.

Equipoise 250 is derived from testosterone and possesses both anabolic and androgenic properties. Its anabolic effects include increased protein synthesis, nitrogen retention, and red blood cell production. These mechanisms can contribute to improved muscle growth, strength, and endurance.

In human use, Equipoise 250 is typically administered through intramuscular injections, with dosages ranging from 200 to 600 mg per week. Due to its long half-life, injections are usually performed once or twice a week. However, it is important to note that the use of Equipoise 250, or any other AAS, for non-medical purposes is considered illegal and unethical in many sports and competitions.

Equipoise 250 can have various side effects, including estrogenic effects such as water retention and potential gynecomastia. Androgenic side effects like acne, increased body hair growth, and male pattern baldness may also occur. Suppression of natural testosterone production is a common side effect, which can lead to hormonal imbalances and the need for post-cycle therapy.